 |
|
|
| |
The impact of M184V/I mutation on the efficacy of
abacavir/lamivudine/dolutegravir regimens prescribed in
treatment-experienced patients
|
| |
| |
Reported by Jules Levin
Glasgow Oct 28-31 2018
Flaminia Olearo*, Nguyen Huyen*, Fabrice Bonnet, Gilles Wandeler,
Marcel Stoeckle, Matthias Cavassini, Alexandra Scherrer, Patrick Schmid,
Jurg Boni, Sabine Yerly, Huldrych Gunthard, Antonella D' Armino, Maurizio
Zazzi, Barbara Rossetti, Pantxika Bellecave, Bart Rijnders, Peter Reiss,
Ferdinand Wit, Roger Kouyos and Alexandra Calmy
|
| |
|
|
|
|
|
